Covered recipient · General Payments record
ABDULHASSAN SAAD
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$30,541.55
- Reported across 212 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $840.00 | 1 |
| Food and Beverage | $302.76 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alkermes, Inc. | $840.00 | 1 |
| Novo Nordisk AS | $250.72 | 24 |
| IBSA Pharma Inc. | $21.62 | 1 |
| PFIZER INC. | $16.68 | 2 |
| GlaxoSmithKline, LLC. | $13.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $840.00 | 07/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120587297 | CMS |
| GlaxoSmithKline, LLC. | $13.74 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116676195 | CMS |
| IBSA Pharma Inc. | $21.62 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142987718 | CMS |
| Novo Nordisk Inc | $7.66 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096791794 | CMS |
| Novo Nordisk Inc | $11.94 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096808406 | CMS |
| Novo Nordisk Inc | $10.38 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096642749 | CMS |
| Novo Nordisk Inc | $11.03 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096939425 | CMS |
| Novo Nordisk Inc | $10.89 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097837359 | CMS |
| Novo Nordisk Inc | $10.63 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097522929 | CMS |
| Novo Nordisk Inc | $9.27 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097266332 | CMS |
| Novo Nordisk Inc | $13.91 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096884439 | CMS |
| Novo Nordisk Inc | $6.14 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097489160 | CMS |
| Novo Nordisk Inc | $9.91 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097401238 | CMS |
| Novo Nordisk Inc | $9.93 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097756303 | CMS |
| Novo Nordisk Inc | $9.59 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096611834 | CMS |
| Novo Nordisk Inc | $6.74 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097661946 | CMS |
| Novo Nordisk Inc | $9.56 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097067051 | CMS |
| Novo Nordisk Inc | $11.84 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096650501 | CMS |
| Novo Nordisk Inc | $11.05 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096648399 | CMS |
| Novo Nordisk Inc | $8.89 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097387141 | CMS |
| Novo Nordisk Inc | $8.68 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096894499 | CMS |
| Novo Nordisk Inc | $8.84 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097222695 | CMS |
| Novo Nordisk Inc | $9.39 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097671245 | CMS |
| Novo Nordisk Inc | $13.38 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097629542 | CMS |
| Novo Nordisk Inc | $13.18 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096603353 | CMS |
| Novo Nordisk Inc | $16.41 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097779530 | CMS |
| Novo Nordisk Inc | $11.48 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096874673 | CMS |
| PFIZER INC. | $9.49 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131841958 | CMS |
| PFIZER INC. | $7.19 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131945816 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.